SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001493152-24-025262
Filing Date
2024-06-26
Accepted
2024-06-26 16:05:41
Documents
9

Document Format Files

Seq Description Document Type Size
1 form424b3.htm 424B3 508314
2 form424b3_001.jpg GRAPHIC 6155
3 form424b3_002.jpg GRAPHIC 12173
4 form424b3_003.jpg GRAPHIC 29427
5 form424b3_004.jpg GRAPHIC 135397
6 form424b3_005.jpg GRAPHIC 38467
7 form424b3_006.jpg GRAPHIC 30687
8 form424b3_007.jpg GRAPHIC 24972
9 form424b3_008.jpg GRAPHIC 16060
  Complete submission text file 0001493152-24-025262.txt   914557
Mailing Address MAXIM 1 2 PARKLANDS WAY HOLYTOWN X0 ML1 4WR
Business Address MAXIM 1 2 PARKLANDS WAY HOLYTOWN X0 ML1 4WR 01414337557
TC BioPharm (Holdings) plc (Filer) CIK: 0001872812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-280000 | Film No.: 241073455
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)